NCT06593964View on ClinicalTrials.gov

TACE With Thermosensitive Nanogel Versus Embosphere for HCC

NARecruitingINTERVENTIONAL
Enrollment

188

Participants

Timeline

Start Date

September 10, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Unresectable Hepatocellular Carcinoma
Interventions
DEVICE

Thermosensitive Nanogel Embolic Agent

Thermosensitive Nanogel Embolic Agent

Trial Locations (1)

Unknown

RECRUITING

Gao-Jun Teng, Nanjing

All Listed Sponsors
lead

Zhongda Hospital

OTHER